Angiogenesis-related molecular targets in esophageal cancer. - Wikidata - awgldk - TriplyDB

Angiogenesis-related molecular targets in esophageal cancer.

Angiogenesis-related molecular targets in esophageal cancer.

http://www.wikidata.org/entity/Q37858534

about

Prediction value of miR-483 and miR-214 in prognosis and multidrug resistance of esophageal squamous cell carcinoma.Drug resistance-related microRNAs in esophageal cancer.Angiogenesis-related microRNAs in colon cancer.miR-210: a therapeutic target in cancer.Epidermal growth factor receptor: an important target in esophageal cancer.Prognosis-related microRNAs in esophageal cancer.MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.Role of microRNA-93 in regulation of angiogenesis.

P2860

Q36889793-C8B4FA2D-0EF3-4001-9EF6-33D962DFA9A7 Q38029108-B5657B1F-894C-460D-B888-0CCAC487AE4C Q38060849-F485B9F3-3B13-4142-B8B2-86DE8C6B01F7 Q38061691-B94E9408-3450-4849-89EE-0A20CA31DECF Q38121640-2EDD3B4D-BEBF-4306-92D0-109C9FC5AECD Q38186129-3A679113-1700-433E-8187-C23D8676A698 Q38202662-8DAEC0B7-74D7-49E0-BC2B-AC93A658E2AA Q38248846-D8FD4CF2-ADD8-40F0-88E2-34352B738812

P2860

Angiogenesis-related molecular targets in esophageal cancer.

http://www.wikidata.org/entity/Q37858534

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Angiogenesis-related molecular targets in esophageal cancer.

@en

Angiogenesis-related molecular targets in esophageal cancer.

@nl

type

label

Angiogenesis-related molecular targets in esophageal cancer.

@en

Angiogenesis-related molecular targets in esophageal cancer.

@nl

prefLabel

Angiogenesis-related molecular targets in esophageal cancer.

@en

Angiogenesis-related molecular targets in esophageal cancer.

@nl

P1433

Q37858534-E61B199D-5896-4481-9CA5-63C1EDC5C47B

P1476

Q37858534-E7557ECA-0477-43DF-991E-D555432BD7D4

P2093

Q37858534-1403BE31-3663-4195-B2D3-CE780C11663E

Q37858534-22CEDA54-FFD0-42BD-ADE1-6761464A3DE5

Q37858534-2A8B076D-DC03-4700-829E-5BCB895BB558

Q37858534-52DCF141-526D-4FB6-9012-E3F477D9F253

Q37858534-997B0260-38B8-4635-B6DB-6AA8AA3E03F3

Q37858534-A8196A33-EE6C-45AE-881C-21B49EB4A257

Q37858534-C3D550D0-25AC-4581-8326-F7A5B4F9B6F4

Q37858534-D1E8AAE5-1FDD-4429-BC4A-97C8E6C68DF2

Q37858534-FE128BAB-F6B8-4053-9A1A-C3EB0CD5E142

P2860

Q37858534-103C1E5E-2B87-438F-A1BC-1CCE62D4F314

Q37858534-166DB2DB-506D-4F30-99F6-869AAB8B933B

Q37858534-1DA76915-A713-442E-B8A1-CAED7A2A1772

Q37858534-20595B78-76F9-4BB3-8727-044D62B0ABEB

Q37858534-20A5F433-6FF1-4574-8B34-A2D191A5F38D

Q37858534-2855F501-2E55-4A64-BB50-89576A8C1E6E

Q37858534-290B51B8-2AD8-47AA-9E95-1E99A5CAF4E3

Q37858534-2D1BCF2A-B909-42C1-AFDD-2209D6044F12

Q37858534-2E8C1C91-BBDA-4765-9F3D-61A9194AC5D5

Q37858534-30FD4E9E-CB0F-43D0-BDD2-AC523BB61310

P304

Q37858534-D87D14CA-CD35-46AA-96ED-55A9CE7DCD1B

P31

Q37858534-000FE706-A136-4724-910F-80462E330AAB

P356

Q37858534-7D9A4720-1785-4D06-A564-02EA0C91D685

P407

Q37858534-B238BDC1-AE4B-41E8-BCCB-D4B4F354E69F

P433

Q37858534-C1C387C3-081A-4283-A19E-3D0DF98BCA33

P478

Q37858534-2062A2D9-10CD-4CC1-BA01-B5DC426BBDDE

P577

Q37858534-EB25D9C8-6BBD-4FCC-8C82-78ADDB985BBD

P698

Q37858534-423D2DF1-D9BA-4C5D-8384-4B1D5F67E65A

P356

13543784.2011.571203

P1433

Expert Opinion on Investigational Drugs

P1476

Angiogenesis-related molecular targets in esophageal cancer.

@en

P2093

Daiming Fan

http://www.w3.org/2001/XMLSchema#string

Hongwei Zhang

http://www.w3.org/2001/XMLSchema#string

Jianjun Du

http://www.w3.org/2001/XMLSchema#string

Jipeng Li

http://www.w3.org/2001/XMLSchema#string

Kaichun Wu

http://www.w3.org/2001/XMLSchema#string

Liu Hong

http://www.w3.org/2001/XMLSchema#string

Qingchuan Zhao

http://www.w3.org/2001/XMLSchema#string

Shujun Li

http://www.w3.org/2001/XMLSchema#string

Yu Han

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy

Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Phase II study of concurrent chemoradiation in combination with erlotinib for locally advanced esophageal carcinoma.

Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study

Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells.

Trastuzumab mediated T-cell response against HER-2/neu overexpressing esophageal adenocarcinoma depends on intact antigen processing machinery.

Imaged-based high-throughput screening for anti-angiogenic drug discovery.

Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis

Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203.

P304

637-644

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2011.571203

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21443389

http://www.w3.org/2001/XMLSchema#string